Detalhe da pesquisa
1.
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer.
Int J Mol Sci
; 24(4)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835014
2.
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Future Oncol
; 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200668
3.
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.
Br J Cancer
; 125(9): 1261-1269, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34493820
4.
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective.
Int J Mol Sci
; 22(15)2021 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360578
5.
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Int J Mol Sci
; 21(19)2020 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33050096
6.
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.
Invest New Drugs
; 36(5): 848-859, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29349598
7.
Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer.
Breast Cancer Res Treat
; 160(1): 69-77, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27628192
8.
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.
J Exp Clin Cancer Res
; 43(1): 10, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167224
9.
AXL - a new player in resistance to HER2 blockade.
Cancer Treat Rev
; 121: 102639, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864955
10.
Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy.
ACS Appl Mater Interfaces
; 15(32): 38323-38334, 2023 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549382
11.
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer.
Cancers (Basel)
; 15(7)2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046799
12.
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Neuro Oncol
; 25(1): 157-166, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639825
13.
Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine.
Clin Cancer Res
; 29(2): 389-400, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346687
14.
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer.
Front Oncol
; 13: 1151496, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188177
15.
Immunological Landscape of HER-2 Positive Breast Cancer.
Cancers (Basel)
; 14(13)2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804943
16.
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
Cancer Treat Rev
; 106: 102392, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436729
17.
mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer.
Mol Cancer Res
; 20(7): 1108-1121, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348729
18.
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.
Sci Adv
; 8(20): eabk2746, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35594351
19.
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer.
Nat Cancer
; 3(3): 355-370, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301507
20.
Fertility and breast cancer: A literature review of counseling, preservation options and outcomes.
Crit Rev Oncol Hematol
; 166: 103461, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461268